Portola Pharmaceuticals Reveals Full Results Of Final Stage APEX Trial Of Betrixaban

By: via Benzinga
Portola Pharmaceuticals Inc. (NASDAQ: PTLA) revealed that the full results of its pivotal final stage APEX (Acute Medically Ill VTE ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.